Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News


November 14, 2012
Will provide launch services for labeled generics  Read More »

November 14, 2012
Provides planning and execution of nonclinical and clinical programs  Read More »

November 13, 2012
Harbauer, Häcki, Kang head ops in Germany, Switzerland and China  Read More »

November 13, 2012
To develop cancer immunotherapies via intra-lymph node injection  Read More »

November 13, 2012
BASi to conduct studies for IND applications  Read More »

November 13, 2012
Will supply SelG1 for Phase II trial   Read More »

November 13, 2012
Lab Services up 26%, driven by China-based labs  Read More »

November 12, 2012
Will provide clinical to commercial quantities  Read More »

November 12, 2012
Expands biospecimen management  Read More »

November 12, 2012
Will develop cervical cancer vaccine  Read More »

November 12, 2012
Includes assets to support IND and BLA  Read More »

November 12, 2012
Will begin PoC trial of Prurisol  Read More »

November 9, 2012
Expands patient access for trials  Read More »

November 9, 2012
Clients include companies from EU, North America, Asia and South America  Read More »

November 9, 2012
Includes license to Chiromics’ chemical compound library  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On